Posted by Michael Wonder on 05 Aug 2015
NICE joins the SMC in recommending the use of Lucentis (ranibizumab) for macular oedema due to retinal vein occlusion
NICE recommends the use of ranibizumab as a possible treatment for some people who have sight problems because of macular oedema caused by retinal vein occlusion. For more details, see:
http://guidance.nice.org.uk/TA283
Posted by:
Michael Wonder
Posted in:
